Oncolytics Biotech Inc.

(ONCY) Trade

By |

Profile

Oncolytics Biotech Inc. is developing an intravenously delivered immuno-oncolytic virus called pelareorep, for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that: 1) induces selective tumor lysis, and 2) promotes an inflamed tumor phenotype through innate and adaptive immune responses. Our clinical development plan is based on these two components of the mechanism of action, with a focus on obtaining regulatory approval as soon as possible.

Contact Information

Website: www.oncolyticsbiotech.com
Email: mmoore@oncolytics.ca
Main Phone: +1 403 670-7377
Address: 1167 Kensington Crescent North West
Address 2: Suite 210
State: AB
City / Town: Calgary
Country: CA
Postal Code: T2N 1X7

Issuer Information

Exchange: NSC
CEO: Matthew C. Coffey
Employees: 22
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Oncolytics Biotech Inc. is developing an intravenously delivered immuno-oncolytic virus called pelareorep, for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that: 1) induces selective tumor lysis, and 2) promotes an inflamed tumor phenotype through innate and adaptive immune responses. Our clinical development plan is based on these two components of the mechanism of action, with a focus on obtaining regulatory approval as soon as possible.

Contact Information

Website: www.oncolyticsbiotech.com
Email: mmoore@oncolytics.ca
Main Phone: +1 403 670-7377
Address: 1167 Kensington Crescent North West
Address 2: Suite 210
State: AB
City / Town: Calgary
Country: CA
Postal Code: T2N 1X7

Issuer Information

Exchange: NSC
CEO: Matthew C. Coffey
Employees: 22
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 1.68 $ -0.0089 (-0.53%)
Last Price 1.68 Change $ -0.0089 Change % -0.53 Tick N/A
Bid 1.69 Bid Size 5,400.00 Ask 1.70 Ask Size 1,100.00
Open 1.75 High 1.75 Low 1.68 Prev Close 1.69
Last Trade Volume 246,452 52 Wk Hi 6.02 52 Wk Low 0.36
Market Cap 70 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 41,656,998.00 EPS (TTM) -0.65 PE Ratio N/A Exchange NCM
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 16.71 16.71 1.76 16.71
Low Target Price Estimate 16.71 16.71 1.76 16.71
Mean Target Price Estimate 16.71 16.71 1.76 16.71
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 05/14/18 05/14/18 05/14/18 05/14/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 1 1 1 1
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.5 2.5 2.5 2.5